Le Lézard
Classified in: Health
Subject: PLW

20/20NOW Announces Efforts To Protect Its Patents Against Infringement


NEW YORK, June 5, 2018 /PRNewswire/ -- 20/20NOW, the pioneer and innovator of Ocular Telehealth, has initiated legal action and other efforts to protect its patents against infringement. 20/20NOW has filed a lawsuit in New York Eastern District Federal Court against Digital Optometrics, claiming infringement of 20/20NOW's intellectual property. The company also intends on filing for a Post Grant Review of Digital Optometrics Patent with the U.S. Patent Office. The company is confident that the recently issued Digital Optometrics Patent will be found invalid.

According to telehealth industry veteran and 20/20NOW CEO Chuck Scott, "20/20NOW has spent numerous years and invested considerable resources developing the know-how and capabilities to conduct comprehensive, in-office vision and eye health testing via telehealth. This includes the issuance of multiple patents covering not only our proprietary exam software but also the systems and methods for testing patient visual acuity and eye health via telehealth.  We simply can't afford to permit, and allow others to copy and use our intellectual property."

Scott shared further, "20/20NOW is dedicated to providing patients access to care, while enabling our clients to conduct high quality, in-office comprehensive eye exams via telehealth.  As such, we have a duty to our shareholders, investors and customers to protect our intellectual property against misuse. As such, we plan to aggressively defend our intellectual property against infringement both now and in the future."

About 20/20NOW
20/20NOW is the pioneer and innovator of ocular telehealth.  Using state-of-the-art technology, proprietary software and patented exam processes, 20/20NOW provides comprehensive eye exams, including eye health screenings, via telehealth. The company's telehealth model allows eye care professionals and optical retailers to provide their patients with increased access to high quality eye exams at a lower cost. 20/20NOW is currently licensed/operating in 17 states.  Over 2.5 million eye exams have been performed worldwide using its proprietary exam software. For more information visit: www.for2020now.com.

20/20NOW
New York, NY
844-843-2020
[email protected]

 

SOURCE 20/20NOW


These press releases may also interest you

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...

at 00:00
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

17 avr 2024
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...

17 avr 2024
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...

17 avr 2024
DaVita Inc. , announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is...



News published on and distributed by: